Business
Moderna Tumbles After Nonpartisan Pledge, First Sell Rating – Bloomberg
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company drew its first sell rating since going public in 2018.
Moderna’s vaccine is one of three leading candidates Wall Street expects may win an emergency use authorization near-term.. But pledges from the Food and Drug Administration and industry leaders have cast a pall over the prospects of a vaccine being approved befor…
-
Noosa News21 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General22 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News10 hours agoAlternative pathways to university explained
-
Noosa News16 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged